With the continuous development and progress of assisted reproductive technologies, the third-generation IVF technology has matured and is now applied clinically, helping numerous families achieve their reproductive plans and obtain healthy babies.

In what specific situations is the third-generation IVF needed?

According to American reproductive experts, nowadays, when couples seek IVF assistance in the United States, doctors typically recommend third-generation IVF, especially for couples of advanced age, those with chromosomal abnormalities, or individuals with a family history of genetic diseases. Through the use of third-generation IVF technology, the effective avoidance of the risk of defects is possible, ensuring the health of future generations and facilitating the achievement of eugenics.

Reproductive specialists explain that third-generation IVF technology, also known as pre-implantation genetic screening and diagnosis (PGS/PGD), involves testing the genetic material of embryos. PGS technology primarily examines the number and structure of chromosomes in embryos to detect abnormalities such as chromosomal deletions, duplications, or translocations. PGD technology, on the other hand, tests the genes on the chromosomes, diagnosing whether the embryos carry defective genes or gene mutations that may lead to certain diseases. Healthy embryos are then selected for implantation, effectively avoiding situations where the fetus may have chromosomal abnormalities, preventing the transmission of genetic diseases to the next generation, and ensuring the health of newborns.

Experts in reproductive medicine in the United States tailor exclusive IVF plans based on the physical condition of both partners, prescribe medications to stimulate the production of high-quality eggs, and use advanced sperm washing techniques to optimize sperm quality.

On this foundation, American IVF experts combine sperm and eggs through intracytoplasmic sperm injection (ICSI) and cultivate the fertilized eggs in high-quality culture medium until they develop into blastocysts on the fifth or sixth day. Subsequently, the third-generation IVF PGS/PGD technology is applied to conduct genetic testing on the embryos, checking for chromosomal abnormalities. Healthy blastocysts are then selected and implanted into the uterus at an appropriate location, thereby increasing the pregnancy rate in women and assisting in the successful birth of healthy children.

Experts in American reproductive medical centers currently utilize advanced third-generation IVF technology, which can screen and diagnose nearly a hundred hereditary diseases, including hemophilia, thalassemia, genetic hearing loss, color blindness, and spinal muscular atrophy, providing better protection for the health of newborns and achieving eugenics.

Note: Thanks to the comprehensive legal and policy support in the United States, there are no restrictions on undergoing third-generation IVF technology in the country. As long as there is a need for reproduction, individuals can go to the United States for IVF assistance, where doctors use advanced IVF techniques to help make the dream of pregnancy come true and achieve fulfillment.